Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Davita Healthcare Partners Inc (DVA)

Davita Healthcare Partners Inc (DVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,279,261
  • Shares Outstanding, K 70,600
  • Annual Sales, $ 12,816 M
  • Annual Income, $ 936,340 K
  • EBIT $ 2,751 M
  • EBITDA $ 3,475 M
  • 60-Month Beta 1.13
  • Price/Sales 0.67
  • Price/Cash Flow 6.35
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 33.72% (-0.45%)
  • Historical Volatility 28.24%
  • IV Percentile 49%
  • IV Rank 31.52%
  • IV High 57.57% on 04/08/25
  • IV Low 22.74% on 02/18/25
  • Expected Move (DTE 3) 3.76 (3.21%)
  • Put/Call Vol Ratio 1.15
  • Today's Volume 258
  • Volume Avg (30-Day) 327
  • Put/Call OI Ratio 1.37
  • Today's Open Interest 25,065
  • Open Int (30-Day) 24,332
  • Expected Range 113.21 to 120.73

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 3.34
  • Number of Estimates 3
  • High Estimate 3.54
  • Low Estimate 3.18
  • Prior Year 2.24
  • Growth Rate Est. (year over year) +49.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
115.39 +1.18%
on 10/31/25
130.82 -10.76%
on 10/29/25
-9.13 (-7.25%)
since 10/17/25
3-Month
115.39 +1.18%
on 10/31/25
141.77 -17.65%
on 08/22/25
-16.50 (-12.38%)
since 08/18/25
52-Week
115.39 +1.18%
on 10/31/25
179.60 -34.99%
on 01/31/25
-40.66 (-25.83%)
since 11/18/24

Most Recent Stories

More News
Barchart’s Technical Indicators Are Flashing ‘Buy’ as Warren Buffett Loads Up on 17.8 Million Shares of Google Stock

Berkshire Hathaway has just released its 13F filing for the third quarter of 2025.

GOOG : 288.51 (+1.02%)
GOOGL : 287.92 (+1.02%)
AAPL : 268.41 (+0.36%)
BAC : 51.92 (+0.85%)
BRK.A : 757,301.00 (+0.25%)
BRK.B : 504.94 (+0.33%)
LAMR : 130.00 (+2.64%)
SIRI : 20.95 (-0.71%)
DVA : 116.83 (-0.38%)
CB : 297.76 (+0.74%)
DPZ : 403.53 (-0.27%)
DaVita Inc. to Participate in Fireside Chat with Wolfe Research

DENVER , Nov. 14, 2025 /PRNewswire/ -- DaVita Inc.  (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat at the Wolfe Research Healthcare...

DVA : 116.83 (-0.38%)
Unpacking Q3 Earnings: DaVita (NYSE:DVA) In The Context Of Other Outpatient & Specialty Care Stocks

Unpacking Q3 Earnings: DaVita (NYSE:DVA) In The Context Of Other Outpatient & Specialty Care Stocks

DVA : 116.83 (-0.38%)
Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know

Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know

JAZZ : 180.08 (+5.87%)
BDX : 192.45 (+0.77%)
AMRX : 11.62 (+0.35%)
PFE : 25.42 (+1.36%)
DVA : 116.83 (-0.38%)
DaVita Stock: Analyst Estimates & Ratings

DaVita has considerably underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.

TFC : 44.51 (+1.34%)
XHS : 101.65 (+0.04%)
$SPX : 6,649.52 (-0.34%)
DVA : 116.83 (-0.38%)
DaVita’s Q3 Earnings Call: Our Top 5 Analyst Questions

DaVita’s Q3 Earnings Call: Our Top 5 Analyst Questions

DVA : 116.83 (-0.38%)
1 Value Stock with Impressive Fundamentals and 2 That Underwhelm

1 Value Stock with Impressive Fundamentals and 2 That Underwhelm

BLBD : 50.69 (+1.38%)
FSUN : 30.91 (+2.49%)
DVA : 116.83 (-0.38%)
DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025

Six  new studies from DaVita Clinical Research spotlight improved outcomes with GLP-1 use, advancements in treatments, transplant access and end-of-life care

DVA : 116.83 (-0.38%)
DVA Q3 2025 Deep Dive: Lower Volumes and Margin Compression Shape Outlook Amid Industry Uncertainty

DVA Q3 2025 Deep Dive: Lower Volumes and Margin Compression Shape Outlook Amid Industry Uncertainty

DVA : 116.83 (-0.38%)
DaVita (NYSE:DVA) Reports Q3 In Line With Expectations

DaVita (NYSE:DVA) Reports Q3 In Line With Expectations

DVA : 116.83 (-0.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals...

See More

Key Turning Points

3rd Resistance Point 125.55
2nd Resistance Point 123.68
1st Resistance Point 120.47
Last Price 116.83
1st Support Level 115.39
2nd Support Level 113.52
3rd Support Level 110.31

See More

52-Week High 179.60
Fibonacci 61.8% 155.07
Fibonacci 50% 147.49
Fibonacci 38.2% 139.92
Last Price 116.83
52-Week Low 115.39

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar